DZ2181A1 - Dénvés d'oxadiazole et de thiadiazole antagonistesdes récepteurs muscariniques. - Google Patents

Dénvés d'oxadiazole et de thiadiazole antagonistesdes récepteurs muscariniques.

Info

Publication number: DZ2181A1
Authority: DZ; Algeria
Prior art keywords: oxadiazole; receptor antagonist; muscarinic receptor; thiadiazole derivatives; thiadiazole
Prior art date: 1996-02-22

Application number

DZ970027A

Other languages

English (en)

Inventor

Alexander Roderick Mackenzie

Anthony Wood

Robert John Bass

Original Assignee

Pfizer Res & Dev Company

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-02-22

Filing date

1997-02-19

Publication date

2002-12-01

1997-02-19 Application filed by Pfizer Res & Dev Company filed Critical Pfizer Res & Dev Company

2002-12-01 Application granted granted Critical

2002-12-01 Publication of DZ2181A1 publication Critical patent/DZ2181A1/fr

Links

229940121948 Muscarinic receptor antagonist Drugs 0.000 title 1
239000003149 muscarinic antagonist Substances 0.000 title 1
WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical compound C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 title 1
150000004867 thiadiazoles Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

DZ970027A 1996-02-22 1997-02-19 Dénvés d'oxadiazole et de thiadiazole antagonistesdes récepteurs muscariniques. DZ2181A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9603755.1A GB9603755D0 (en)	1996-02-22	1996-02-22	Therapeutic agents

Publications (1)

Publication Number	Publication Date
DZ2181A1 true DZ2181A1 (fr)	2002-12-01

Family

ID=10789217

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ970027A DZ2181A1 (fr)	1996-02-22	1997-02-19	Dénvés d'oxadiazole et de thiadiazole antagonistesdes récepteurs muscariniques.

Country Status (42)

Country	Link
US (1)	US5977142A (fr)
EP (1)	EP0885218B1 (fr)
JP (1)	JP3148252B2 (fr)
KR (1)	KR100315934B1 (fr)
CN (1)	CN1089340C (fr)
AP (1)	AP751A (fr)
AR (1)	AR005916A1 (fr)
AT (1)	ATE200899T1 (fr)
AU (1)	AU712230B2 (fr)
BG (2)	BG102699A (fr)
BR (1)	BR9707733A (fr)
CA (1)	CA2247164C (fr)
CO (1)	CO4650040A1 (fr)
CZ (1)	CZ292650B6 (fr)
DE (1)	DE69704701T2 (fr)
DK (1)	DK0885218T3 (fr)
DZ (1)	DZ2181A1 (fr)
ES (1)	ES2156357T3 (fr)
GB (1)	GB9603755D0 (fr)
GR (1)	GR3036032T3 (fr)
HN (1)	HN1997000020A (fr)
HR (1)	HRP970098B1 (fr)
HU (1)	HUP9900501A3 (fr)
ID (1)	ID16642A (fr)
IL (1)	IL125413A (fr)
IS (1)	IS4803A (fr)
MY (1)	MY129729A (fr)
NO (1)	NO313414B1 (fr)
NZ (1)	NZ331039A (fr)
OA (1)	OA10838A (fr)
PE (1)	PE42798A1 (fr)
PL (1)	PL186879B1 (fr)
PT (1)	PT885218E (fr)
RU (1)	RU2162848C2 (fr)
SK (1)	SK283461B6 (fr)
TN (1)	TNSN97039A1 (fr)
TR (1)	TR199801644T2 (fr)
TW (1)	TW492961B (fr)
UA (1)	UA61068C2 (fr)
WO (1)	WO1997030994A1 (fr)
YU (1)	YU35698A (fr)
ZA (1)	ZA971513B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6107313A (en) *	1998-10-02	2000-08-22	Combichem, Inc.	Dopamine receptor antagonists
CA2438991C (fr) *	2001-02-21	2010-08-17	Nps Pharmaceuticals, Inc.	Composes heteropolycycliques et leur utilisations en tant qu'antagonistes des recepteurs metabotropiques du glutamate
GB0510141D0 (en) *	2005-05-18	2005-06-22	Addex Pharmaceuticals Sa	Novel compounds B3
GB0510139D0 (en) *	2005-05-18	2005-06-22	Addex Pharmaceuticals Sa	Novel compounds B1
GB0516313D0 (en)	2005-08-08	2005-09-14	Argenta Discovery Ltd	Azole derivatives and their uses
WO2008017827A2 (fr) *	2006-08-08	2008-02-14	Argenta Discovery Limited	Composés chimiques
JP2010501533A (ja) *	2006-08-21	2010-01-21	アージェンタディスカバリーリミテッド	Ｍ３レセプター調節物質として有用な窒素含有複素環化合物
WO2008096093A1 (fr) *	2007-02-06	2008-08-14	Argenta Discovery Ltd.	Dérivés d'oxazole et de thiazole et leurs utilisations
GB0702414D0 (en) *	2007-02-07	2007-03-21	Argenta Discovery Ltd	Oxazole and thiazole derivatives and their uses 2
GB0702385D0 (en) *	2007-02-07	2007-03-21	Argenta Discovery Ltd	New combination
BRPI0807004A2 (pt) *	2007-02-07	2014-04-15	Argenta Discovery Ltd	Sal
GB0702382D0 (en) *	2007-02-07	2007-03-21	Argenta Discovery Ltd	New salt
GB0702416D0 (en) *	2007-02-07	2007-03-21	Argenta Discovery Ltd	New combination
TW200843759A (en) *	2007-02-15	2008-11-16	Argenta Discovery Ltd	Compounds and their use II
WO2009098453A1 (fr) *	2008-02-06	2009-08-13	Astrazeneca Ab	Azonia bicycloalcanes comme antagonistes du récepteur d'acétylcholine muscarinique m3
US8263623B2 (en)	2008-07-11	2012-09-11	Pfizer Inc.	Triazol derivatives useful for the treatment of diseases
WO2010018352A1 (fr) *	2008-08-12	2010-02-18	Argenta Discovery Limited	Composés hétérocycliques utilisés dans le traitement de maladies impliquant l’activation améliorée du récepteur m3
JP2014065387A (ja) *	2012-09-25	2014-04-17	Showa Corp	自動二輪車の車高調整装置

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ219646A (en) *	1986-03-27	1990-10-26	Merck Sharp & Dohme	Oxadiazole derivatives of azacyclics for treating cns disorders
IL88846A0 (en) *	1988-01-08	1989-07-31	Merck Sharp & Dohme	Lipophilic oxadiazoles,their preparation and pharmaceutical compositions containing them
US5043345A (en) *	1989-02-22	1991-08-27	Novo Nordisk A/S	Piperidine compounds and their preparation and use
EP0619814A1 (fr) *	1991-12-31	1994-10-19	Fujisawa Pharmaceutical Co., Ltd.	Derives d'oxadiazole a effet inhibiteur de l'acetylcholinesterase et agoniste muscarinique
TW360653B (en) *	1995-03-01	1999-06-11	Janssen Pharmaceutica Nv	A oxadiazole compound having colon motility stimulating properties, its preparation process and its pharmaceutical composition

1996
- 1996-02-22 GB GBGB9603755.1A patent/GB9603755D0/en active Pending
1997
- 1997-01-21 TW TW086100642A patent/TW492961B/zh not_active IP Right Cessation
- 1997-02-03 HN HN1997000020A patent/HN1997000020A/es unknown
- 1997-02-04 AU AU16014/97A patent/AU712230B2/en not_active Ceased
- 1997-02-04 KR KR1019980706534A patent/KR100315934B1/ko not_active Expired - Fee Related
- 1997-02-04 SK SK1123-98A patent/SK283461B6/sk unknown
- 1997-02-04 PT PT97902337T patent/PT885218E/pt unknown
- 1997-02-04 WO PCT/EP1997/000525 patent/WO1997030994A1/fr not_active Ceased
- 1997-02-04 NZ NZ331039A patent/NZ331039A/en unknown
- 1997-02-04 AT AT97902337T patent/ATE200899T1/de not_active IP Right Cessation
- 1997-02-04 CA CA002247164A patent/CA2247164C/fr not_active Expired - Fee Related
- 1997-02-04 HU HU9900501A patent/HUP9900501A3/hu unknown
- 1997-02-04 ES ES97902337T patent/ES2156357T3/es not_active Expired - Lifetime
- 1997-02-04 DK DK97902337T patent/DK0885218T3/da active
- 1997-02-04 PL PL97328633A patent/PL186879B1/pl not_active IP Right Cessation
- 1997-02-04 IL IL12541397A patent/IL125413A/en not_active IP Right Cessation
- 1997-02-04 US US09/117,556 patent/US5977142A/en not_active Expired - Fee Related
- 1997-02-04 RU RU98117457/04A patent/RU2162848C2/ru not_active IP Right Cessation
- 1997-02-04 JP JP52974197A patent/JP3148252B2/ja not_active Expired - Fee Related
- 1997-02-04 DE DE69704701T patent/DE69704701T2/de not_active Expired - Fee Related
- 1997-02-04 EP EP97902337A patent/EP0885218B1/fr not_active Expired - Lifetime
- 1997-02-04 CN CN97192486A patent/CN1089340C/zh not_active Expired - Fee Related
- 1997-02-04 BR BR9707733A patent/BR9707733A/pt not_active Application Discontinuation
- 1997-02-04 TR TR1998/01644T patent/TR199801644T2/xx unknown
- 1997-02-04 CZ CZ19982678A patent/CZ292650B6/cs not_active IP Right Cessation
- 1997-02-13 CO CO97007550A patent/CO4650040A1/es unknown
- 1997-02-14 PE PE1997000104A patent/PE42798A1/es not_active Application Discontinuation
- 1997-02-19 DZ DZ970027A patent/DZ2181A1/fr active
- 1997-02-19 TN TNTNSN97039A patent/TNSN97039A1/fr unknown
- 1997-02-20 AP APAP/P/1997/000930A patent/AP751A/en active
- 1997-02-20 AR ARP970100667A patent/AR005916A1/es unknown
- 1997-02-20 HR HR970098A patent/HRP970098B1/xx not_active IP Right Cessation
- 1997-02-21 ZA ZA971513A patent/ZA971513B/xx unknown
- 1997-02-21 ID IDP970521A patent/ID16642A/id unknown
- 1997-02-21 MY MYPI97000654A patent/MY129729A/en unknown
- 1997-04-02 UA UA98094939A patent/UA61068C2/uk unknown
1998
- 1998-07-21 IS IS4803A patent/IS4803A/is unknown
- 1998-08-14 OA OA9800143A patent/OA10838A/en unknown
- 1998-08-19 BG BG102699A patent/BG102699A/xx unknown
- 1998-08-19 BG BG102699A patent/BG63971B1/bg unknown
- 1998-08-21 NO NO19983871A patent/NO313414B1/no not_active IP Right Cessation
- 1998-08-21 YU YU35698A patent/YU35698A/sh unknown
2001
- 2001-06-13 GR GR20010400885T patent/GR3036032T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
CN1211981A (zh)	1999-03-24
BG63971B1 (bg)	2003-08-29
CN1089340C (zh)	2002-08-21
GR3036032T3 (en)	2001-09-28
CO4650040A1 (es)	1998-09-03
HRP970098A2 (en)	1999-04-30
WO1997030994A1 (fr)	1997-08-28
IS4803A (is)	1998-07-21
ID16642A (id)	1997-10-23
SK283461B6 (sk)	2003-08-05
KR19990087143A (ko)	1999-12-15
TR199801644T2 (xx)	1998-11-23
BG102699A (en)	1999-09-30
PE42798A1 (es)	1998-08-18
TW492961B (en)	2002-07-01
SK112398A3 (en)	2000-04-10
DE69704701T2 (de)	2001-08-16
HN1997000020A (es)	1997-06-05
AR005916A1 (es)	1999-07-21
NO313414B1 (no)	2002-09-30
US5977142A (en)	1999-11-02
AU712230B2 (en)	1999-11-04
JPH11504051A (ja)	1999-04-06
HRP970098B1 (en)	2001-12-31
AP751A (en)	1999-07-12
AP9700930A0 (en)	1997-04-30
NO983871D0 (no)	1998-08-21
RU2162848C2 (ru)	2001-02-10
UA61068C2 (en)	2003-11-17
CA2247164C (fr)	2004-11-16
KR100315934B1 (ko)	2002-03-21
CZ267898A3 (cs)	1999-08-11
MY129729A (en)	2007-04-30
OA10838A (en)	2001-08-13
CA2247164A1 (fr)	1997-08-28
IL125413A0 (en)	1999-03-12
EP0885218B1 (fr)	2001-05-02
ES2156357T3 (es)	2001-06-16
EP0885218A1 (fr)	1998-12-23
PT885218E (pt)	2001-08-30
TNSN97039A1 (fr)	2005-03-15
HK1018274A1 (en)	1999-12-17
ZA971513B (en)	1998-08-21
JP3148252B2 (ja)	2001-03-19
AU1601497A (en)	1997-09-10
BR9707733A (pt)	1999-07-27
DE69704701D1 (de)	2001-06-07
PL186879B1 (pl)	2004-03-31
IL125413A (en)	2002-09-12
HUP9900501A2 (hu)	1999-06-28
HUP9900501A3 (en)	2001-02-28
YU35698A (sh)	1999-07-28
NZ331039A (en)	1999-10-28
NO983871L (no)	1998-08-21
GB9603755D0 (en)	1996-04-24
DK0885218T3 (da)	2001-05-28
CZ292650B6 (cs)	2003-11-12
PL328633A1 (en)	1999-02-15
ATE200899T1 (de)	2001-05-15

Publication	Publication Date	Title
EP0934305A4 (fr)	2001-04-11	Antagonistes de l'integrine
EP0865867A4 (fr)	2002-05-15	Dispositif d'usinage
EP1007026A4 (fr)	2002-08-07	Antagonistes d'integrine
FR2765931B1 (fr)	2000-11-24	Dispositif d'amortissement
NO972016D0 (no)	1997-04-30	Indolyl-Y-reseptorantagonister
DE69734833D1 (de)	2006-01-12	Vitronektin rezeptor antagonisten
DE69728392D1 (de)	2004-05-06	Indolderivate verwendbar als endothelinrezeptorantagonisten
EP1100506A4 (fr)	2002-06-26	Antagonistes des recepteurs de l'integrine
EP0612244A4 (fr)	1995-05-17	Antagonistes recepteurs de l'endotheline.
DZ1773A1 (fr)	2002-02-17	Antagonistes de récepteurs d'endothéline.
EP0810994A4 (fr)	1998-05-06	Antagonistes des recepteurs de fibrinogene
GB9020051D0 (en)	1990-10-24	Muscarinic receptor antagonists
NO975976D0 (no)	1997-12-19	Vitronektinreseptor-antagonister, fremstilling samt anvendelse derav
EP0885205A4 (fr)	2002-11-27	Antagonistes des recepteurs de fibrinogenes
NO983871L (no)	1998-08-21	Oksa- og tiadiazol muskarinreseptorantagonister
NO975975D0 (no)	1997-12-19	Vitronektinreseptor-antagonister, fremstilling samt anvendelse derav
TR199800988A3 (tr)	1998-12-21	5' Deoksi-Sitidin türevleri.
EP0684823A4 (fr)	1997-07-09	Antagonistes des recepteurs de fibrinogene.
FR2745640B1 (fr)	1998-04-10	Dispositif d'imagerie multicoupes
FR2748318B1 (fr)	2001-03-30	Dispositif d'injection de plasma
DE69427921D1 (de)	2001-09-13	Epsilon opioid rezeptor und dessen verwendungen
FI894675A7 (fi)	1990-04-05	Muskarinreceptorantagonister.
DE69616364D1 (de)	2001-11-29	Endothelinrezeptorantagonisten
EP0999205A4 (fr)	2000-05-31	Composes d'aminocycloalcane
FI950209L (fi)	1995-01-18	Farmakologisesti aktiiviset alfa-(tertiaarinen-amino-metyyli)-bentseenimetanolijohdannaiset